Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cory M,Vela

第一单位： University of Kentucky Markey Cancer Center, Lexington, KY; , , , , , , , and , H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

作者： Cory M,Vela ^[1] ; Magali,Van den Bergh ^[1] ; Nancy K,Gillis ^[1] ; Markus,Ball ^[1] ; Mohammad O,Hussaini ^[1] ; Christine M,Walko ^[1] ; J Kevin,Hicks ^[1] ; Lia,Perez ^[1] ; Eric,Padron ^[1] ; Rami S,Komrokji ^[1]

作者单位： University of Kentucky Markey Cancer Center, Lexington, KY; , , , , , , , and , H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. ^[1]

DOI 10.1200/PO.17.00110

PMID 35135101

发布时间 2022-12-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCO precision oncology

2018年2卷

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential.

JCO precision oncology

相似文献

JCO precision oncology

相关期刊

检索历史清除